Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:34 PM
Ignite Modification Date:
2025-12-24 @ 6:34 PM
NCT ID:
NCT05970757
Eligibility Criteria:
Inclusion Criteria:
* Informed consent;
* Adults (18 years or older);
* diagnosed with IDH-wildtype glioblastoma, as confirmed by pathology including molecular analysis post resection/biopsy;
* referred to outpatient clinic of the Department of Radiotherapy to undergo standard treatment with high-dose RT.
* Patients eligible for 30x2Gy or 15x2.67Gy
Exclusion Criteria:
* Contraindication for MRI
* Contraindication for use of gadolinium-based contrast agent (i.e. subject having renal deficiency)
* Unable to give informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05970757
Study Brief:
Protocol Section:
NCT05970757